Research-ready sites. One model
A growing Canadian clinical site network, supported by one operating model.
MD Trials Sites helps established specialty clinics build and sustain clinical-research capability. We provide the operational infrastructure around the investigator — feasibility, start-up, ethics support, contracts and budgets, coordination, documentation, sponsor and CRO interface, and quality systems — so research can operate reliably alongside clinical practice.
The network is anchored by sites in Alberta, with additional sites in development. For sponsors and CROs, MDTrials provides realistic site feasibility, coordinated activation and a consistent operating interface across qualified managed sites.
For Sponsors & CROs
Evaluate Canadian sites with realistic feasibility, clear capability data and coordinated activation. Where multiple MD Trials - managed sites are appropriate, we can provide one operating interface while keeping site-specific investigator responsibility and contracting clear.
For Clinics & Investigators
Build or strengthen a research program without recreating the operational infrastructure alone. MD Trials provides the systems, people and trial-administration support around your practice while you retain investigator responsibility for the clinical trial.
Growth in proportion to real demand
How the model works
We generally build research capability around existing clinical practices rather than creating stand-alone facilities first. That keeps investigators close to their patient populations and allows site infrastructure to grow in proportion to real study demand. Equipment, staffing and procedures are expanded only where the site and incoming protocols justify them.
Anchored in IBD. Expanding deliberately
Current therapeutic footprint
The network operates on two tiers. Operating sites are sponsor-ready: qualified investigators, trained coordination, documented capability, and monitoring-ready practice — currently anchored in inflammatory bowel disease and gastroenterology, with hepatology as the next planned expansion. Development sites are clinics in staged build — investigator training, governance, and infrastructure — across selected additional specialties; they are not marketed to sponsors until they can pass a feasibility assessment honestly. Sponsors should treat the network footprint as distinct from the broader therapeutic experience of MD Trials CRO; we confirm site-level capability at feasibility rather than implying network-wide coverage.
Frequent Questions
- What does a site management organization do?An SMO provides the operational infrastructure around a clinical trial site: feasibility, start-up and ethics submissions, contracts and budgets, coordinator staffing, documentation, data entry support, monitoring readiness and sponsor communication. The investigator retains clinical and regulatory responsibility for the trial.
- How many sites are in the network?The network is anchored by two clinics in Alberta, with additional sites in development. Additional clinics are in staged development and are not marketed to sponsors until they are genuinely ready. We publish capability site by site rather than as a network-wide claim, and we will give you the current position directly.
- Can sponsors work with your sites without engaging MDTrials CRO?Yes. Sponsors and CROs can engage MDTrials Sites independently without engaging MDTrials CRO.
CONTACT US
Introduces the MDTrials Sites network — Canadian, sponsor-ready, and built to help specialty clinics sustain research alongside patient care.